Wayne Koberstein

By Wayne Koberstein, Executive Editor, Life Science Leader Follow Me On Twitter @WayneKoberstein To protect and restore neuronal networks by enhancing natural repair processes. Snapshot Athira Pharma takes a small-molecule approach to targeting the neurotrophic hepatocyte growth factor (HGF) system for neurodegenerative diseases.

By Wayne Koberstein, Executive Editor, Life Science Leader Follow Me On Twitter @WayneKoberstein Resalis Enters the Widening Space of Weight Loss Discovery and accident are two words married at the hip. If you’re in the business of discovery, you should prepare for the fortunate accident, the kind that shows a pathway to something new and beneficial, one that takes you away from your original goal entirely and guides you thereafter toward a brand new destination.

By Wayne Koberstein, Executive Editor, Life Science Leader magazine Follow Me On Twitter @WayneKoberstein Inozyme’s Leader Shares Informed Views In the decades since the United States passed the Orphan Drug Act in 1983, its policies have succeeded in raising the number of drugs developed for rare diseases. Incentives in the Act were so effective, in fact, orphan drugs may have replaced blockbusters as the driving force of biopharma.